Viking Therapeutics, Inc. (LON:0VQA)
27.11
+0.30 (1.11%)
At close: Jun 30, 2025
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-2.16M GBP
Market Cap
2.19B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Indivior | 1,051 |
Viking Therapeutics News
- 7 days ago - What's Going On With Viking Therapeutics Stock On Wednesday? - Benzinga
- 7 days ago - Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735 - PRNewsWire
- 4 weeks ago - Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha
- 4 weeks ago - Could Viking Therapeutics Become the Next Eli Lilly? - The Motley Fool
- 4 weeks ago - Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade) - Seeking Alpha
- 5 weeks ago - Viking Therapeutics: Buy It For The Future And Ignore The Noise - Seeking Alpha
- 5 weeks ago - Better Weight Loss Stock: Amgen or Viking Therapeutics? - The Motley Fool
- 5 weeks ago - Viking Therapeutics: Weight-Loss Story Remains Intact - Seeking Alpha